Skylake Capital

Skylake Capital is a London-based investment firm established in 2019 that specializes in technology investments within the enterprise IT infrastructure sector. The firm focuses on identifying and supporting seed-stage and Series A startups, primarily across Europe and Israel. By concentrating on early-stage companies, Skylake Capital aims to foster innovation and growth in the technology landscape.

Marcos Battisti

General Partner

2 past transactions

Noogata

Seed Round in 2021
Noogata is an AI-powered eCommerce platform designed to provide insights and strategic guidance for consumer packaged goods (CPG) companies, digital brands, and agencies. The platform simplifies the discovery of insights, enabling eCommerce professionals to access competitive intelligence, consumer search insights, and AI tools that enhance digital shelf performance. Noogata's growth assistant monitors a vast array of products and categories, delivering actionable insights that help brands optimize their sales, advertising, and pricing strategies. By streamlining competitive data and making it easy to visualize and measure, Noogata enables its clients to outperform competitors and improve their presence in the digital marketplace. The company is supported by prominent venture capital firms, including Team8 and Eight Roads Capital.

Mindtrace

Seed Round in 2021
Mindtrace has built Artificial Intelligence that is brain-inspired and delivers an intelligent system that is trained using ‘few shot learning’ as we teach a human! The goal to develop novel neuromorphic algorithms that automatically make intelligent decisions in a measured and predictable manner. The intelligent machines can continuously and autonomously learn about real world use cases using as few as 20 images or instances in as little as 10 working days! The knowledge for predictive decision-making increases detections, identifying data from 2D and 3D images, laser scans, LiDAR or even ultrasonic outputs in a fraction of a second for any industry or use such as manufacturing, aerospace, automotive, asset inspection, pharma, military and healthcare where Mindtrace can detect anomalies in cells and accurately identify cancer cells and event heart defects, saving 3,000 clinician days a year.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.